Intratumour Fusobacterium nucleatum and immune response to oesophageal cancer

被引:10
|
作者
Kosumi, Keisuke [1 ,2 ,3 ]
Baba, Yoshifumi [1 ,3 ]
Yamamura, Kensuke [1 ]
Nomoto, Daichi [1 ]
Okadome, Kazuo [1 ,4 ,5 ]
Yagi, Taisuke [1 ]
Toihata, Tasuku [1 ]
Kiyozumi, Yuki [1 ]
Harada, Kazuto [1 ]
Eto, Kojiro [1 ]
Sawayama, Hiroshi [1 ]
Ishimoto, Takatsugu [1 ,6 ]
Iwatsuki, Masaaki [1 ]
Iwagami, Shiro [1 ]
Miyamoto, Yuji [1 ]
Yoshida, Naoya [1 ]
Watanabe, Masayuki [7 ]
Baba, Hideo [1 ,8 ]
机构
[1] Kumamoto Univ, Grad Sch Med Sci, Dept Gastroenterol Surg, 1-1-1 Honjo,Chuo Ku, Kumamoto 8608556, Japan
[2] Amakusa Med Ctr, Dept Surg, 854-1 Jikiba, Amakusa 8630046, Japan
[3] Kumamoto Univ, Grad Sch Med Sci, Dept Next Generat Surg Therapy Dev, 1-1-1 Honjo,Chuo Ku, Kumamoto 8608556, Japan
[4] Brigham & Womens Hosp, Dept Pathol, Program MPE Mol Pathol Epidemiol, 221 Longwood Ave,EBRC Room 404A, Boston, MA 02115 USA
[5] Harvard Med Sch, 221 Longwood Ave,EBRC Room 404A, Boston, MA 02115 USA
[6] Kumamoto Univ, Int Res Ctr Med Sci IRCMS, Gastrointestinal Canc Biol, 2-2-1 Honjo,Chuo Ku, Kumamoto 8600811, Japan
[7] Canc Inst Hosp, Japanese Fdn Canc Res, Dept Gastroenterol Surg, 3-8-31 Ariake,Koto Ku, Tokyo 1358550, Japan
[8] Kumamoto Univ, Ctr Metab Regulat Hlth Aging, 1-1-1 Honjo,Chuo Ku, Kumamoto 8608556, Japan
基金
日本学术振兴会;
关键词
COLORECTAL-CANCER; LYMPHOCYTIC REACTION; PATIENT SURVIVAL; T-CELLS; EXPRESSION; IMMUNOTHERAPY; PERSISTENCE; MICROBIOME; PROGNOSIS; THERAPY;
D O I
10.1038/s41416-022-02112-x
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Experimental evidence suggests a role of intratumour Fusobacterium nucleatum in the aggressive behaviour of gastrointestinal cancer through downregulating anti-tumour immunity. We investigated the relationship between intratumour F. nucleatum and immune response to oesophageal cancer. Methods: Utilising an unbiased database of 300 resected oesophageal cancers, we measured F. nucleatum DNA in tumour tissue using a quantitative polymerase chain reaction assay, and evaluated the relationship between the abundance of F. nucleatum and the densities of T cells (CD8 + , FOXP3 + and PDCD1 + ), as well as lymphocytic reaction patterns (follicle lymphocytic reaction, peritumoural lymphocytic reaction, stromal lymphocytic reaction and tumour-infiltrating lymphocytes) in oesophageal carcinoma tissue. Results: F. nucleatum was significantly and inversely associated only with the peritumoural lymphocytic reaction (P = 0.0002). Compared with the F. nucleatum-absent group, the F. nucleatum-high group showed a much lower level of the peritumoural lymphocytic reaction (univariable odds ratio, 0.33; 95% confidence interval, 0.16-0.65; P = 0.0004). A multivariable model yielded a similar finding (multivariable odds ratio, 0.34; 95% confidence interval 0.16-0.69; P = 0.002). Conclusions: Intratumour F. nucleatum is associated with a diminished peritumoural lymphocytic reaction, providing a platform for further investigations on the potential interactive roles between intratumour F. nucleatum and host immunity.
引用
收藏
页码:1155 / 1165
页数:11
相关论文
共 50 条
  • [1] Intratumour Fusobacterium nucleatum and immune response to oesophageal cancer
    Keisuke Kosumi
    Yoshifumi Baba
    Kensuke Yamamura
    Daichi Nomoto
    Kazuo Okadome
    Taisuke Yagi
    Tasuku Toihata
    Yuki Kiyozumi
    Kazuto Harada
    Kojiro Eto
    Hiroshi Sawayama
    Takatsugu Ishimoto
    Masaaki Iwatsuki
    Shiro Iwagami
    Yuji Miyamoto
    Naoya Yoshida
    Masayuki Watanabe
    Hideo Baba
    British Journal of Cancer, 2023, 128 : 1155 - 1165
  • [2] Fusobacterium nucleatum and the Immune System in Colorectal Cancer
    Borroni, Elena Monica
    Qehajaj, Dorina
    Farina, Floriana Maria
    Yiu, Daniel
    Bresalier, Robert S.
    Chiriva-Internati, Maurizio
    Mirandola, Leonardo
    Stifter, Sanja
    Laghi, Luigi
    Grizzi, Fabio
    CURRENT COLORECTAL CANCER REPORTS, 2019, 15 (05) : 149 - 156
  • [3] Fusobacterium nucleatum: a novel immune modulator in breast cancer?
    Little, Alexa
    Tangney, Mark
    Tunney, Michael M.
    Buckley, Niamh E.
    EXPERT REVIEWS IN MOLECULAR MEDICINE, 2023, 25
  • [4] Fusobacterium nucleatum and cancer
    Alon-Maimon, Tamar
    Mandelboim, Ofer
    Bachrach, Gilad
    PERIODONTOLOGY 2000, 2022, 89 (01) : 166 - 180
  • [5] Autoaggregation Response of Fusobacterium nucleatum
    Merritt, Justin
    Niu, Guoqing
    Okinaga, Toshinori
    Qi, Felicia
    APPLIED AND ENVIRONMENTAL MICROBIOLOGY, 2009, 75 (24) : 7725 - 7733
  • [6] Fusobacterium nucleatum in Colorectal Cancer Relates to Immune Response Differentially by Tumor Microsatellite Instability Status
    Hamada, Tsuyoshi
    Zhang, Xuehong
    Mima, Kosuke
    Bullman, Susan
    Sukawa, Yasutaka
    Nowak, Jonathan A.
    Kosumi, Keisuke
    Masugi, Yohei
    Twombly, Tyler S.
    Cao, Yin
    Song, Mingyang
    Liu, Li
    da Silva, Annacarolina
    Shi, Yan
    Gu, Mancang
    Li, Wanwan
    Koh, Hideo
    Nosho, Katsuhiko
    Inamura, Kentaro
    Keum, NaNa
    Wu, Kana
    Meyerhardt, Jeffrey A.
    Kostic, Aleksandar D.
    Huttenhower, Curtis
    Garrett, Wendy S.
    Meyerson, Matthew
    Giovannucci, Edward L.
    Chan, Andrew T.
    Fuchs, Charles S.
    Nishihara, Reiko
    Giannakis, Marios
    Ogino, Shuji
    CANCER IMMUNOLOGY RESEARCH, 2018, 6 (11) : 1327 - 1336
  • [7] Fusobacterium nucleatum and colon cancer
    Garrett, Wendy S.
    CANCER IMMUNOLOGY RESEARCH, 2018, 6 (09)
  • [8] Fusobacterium nucleatum and Colorectal Cancer
    Li, Rongrong
    Shen, Jilu
    Xu, Yuanhong
    INFECTION AND DRUG RESISTANCE, 2022, 15 : 1115 - 1120
  • [9] Immune response to Fusobacterium nucleatum and Prevotella intermedia in patients with infectious mononucleosis
    Brook, I
    DeLeyva, F
    JOURNAL OF MEDICAL MICROBIOLOGY, 1996, 44 (02) : 131 - 134
  • [10] FUSOBACTERIUM NUCLEATUM AND ITS EFFECTS ON TREATMENT RESPONSE IN RECTAL CANCER
    Hanna, Marina
    Yu, Ming
    Cannon, Victoria
    Carter, Kelly
    Vickers, Kathy
    Li, Christopher I.
    Cohen, Stacey A.
    Krane, Mukta K.
    Reddi, Deepti
    Ulrich, Cornelia
    Grady, William M.
    GASTROENTEROLOGY, 2022, 162 (07) : S1002 - S1002